AnnexMedAnnexMedAnnexMed
Corporate Office
USA
299 S. Main Street
Suite 1300
Salt Lake City, UT 84111
Chennai - Tower I
CeeDeeYes Tyche Towers,
Block-1 3rd Floor, Perungudi Bypass Rd, Perungudi,
Chennai - 600096
Chennai - Tower II
4th Floor, IIFL TOWERS
MGR Main Rd,
Perungudi, Chennai - 600096
Villupuram
No 9, Viswalingam Layout
Villupuram,
Tamil Nadu – 605602

Manufacturer Assistance Programs

Active Enrollment in Manufacturer Patient Assistance Programs at Specialty Scale

Active enrollment in manufacturer Patient Assistance Programs (PAP), free drug programs, bridge programs, and quick-start programs across the major specialty drug manufacturers — with eligibility verification, documentation coordination, and recertification cycle management built for specialty pharmacy volume.

95%+

Enrollment Accuracy

48 HRS

Average Enrollment Turnaround

90%+

Recertification Success Rate

The Reality

Why manufacturer patient assistance programs are the most underutilized specialty pharmacy access lever?

Every major specialty drug manufacturer operates a Patient Assistance Program providing free or low-cost medication for income-eligible uninsured and underinsured patients. These programs are designed for exactly the patient populations specialty pharmacy serves — high-cost biologic, oncology,

immunology, and rare disease therapy where uninsured or financially-stressed patients can’t afford full-price medication. Despite the financial fit, most specialty pharmacy operations enroll only a small fraction of eligible patients. The gap between eligibility and enrollment is where therapy access fails and revenue gets written off.

Program-Specific Eligibility Criteria

Each manufacturer PAP operates different eligibility criteria — different income thresholds, different insurance status requirements, different diagnosis requirements, different documentation standards. Pharmacies running generic PAP workflow against program-specific criteria face systematic enrollment failures.

Documentation Burden at Specialty Scale

PAP enrollment requires income documentation (tax returns, pay stubs, benefit letters), insurance status verification, prescriber attestation, and diagnostic documentation. Multiplied across hundreds or thousands of potentially-eligible specialty patients annually, the documentation work is operationally substantial.

Recertification Cycle Management

Approved PAP enrollments typically expire annually and require recertification. Patients on continuing specialty therapy need uninterrupted PAP coverage — and missed recertification cycles drop them out of the program mid-therapy. Without dedicated recertification infrastructure, PAP enrollments lapse on the same continuing patients PAP is designed to support.

Bridge and Quick-Start Program Coordination

Many manufacturers operate bridge programs (covering medication during PA processing) and quick-start programs (initial supply while PAP enrollment processes). These programs prevent therapy delays but require coordinated workflow that most specialty pharmacy operations don't actively manage.

Free Drug Program Operational Complexity

Free drug programs require shipment coordination, patient enrollment tracking, pharmacy operational workflow integration, and dispensing documentation. The free drug pathway operates differently from standard billed dispensing, and most pharmacy operations aren't built for it.

Manufacturer Program Changes

Manufacturer PAP eligibility criteria, program scope, and enrollment workflows change throughout the year. Pharmacies running on stale program data submit enrollments that get rejected for criteria that have shifted. Quarterly program intelligence is required to keep enrollment success rates current.

Our approach

We run manufacturer pap enrollment as standing specialty pharmacy capability

AnnexMed runs manufacturer Patient Assistance Program enrollment as dedicated specialty pharmacy capability — with program-specific eligibility workflow across the major specialty manufacturers, active documentation coordination, recertification cycle management, bridge and quick-start program integration, and quarterly program intelligence updates. PAP enrollment becomes a standard access lever for eligible patients instead of a reactive workflow when patients can’t afford therapy.

We serve specialty pharmacies, infusion centers, and home infusion providers where uninsured and underinsured specialty patient populations represent meaningful operational reality. Our team manages PAP enrollment across major manufacturers — AbbVie myAbbVie Assist, Genentech Access Solutions, Pfizer RxPathways, Novartis Patient Assistance Foundation, Bristol Myers Squibb Patient Assistance Foundation, Eli Lilly Cares, AstraZeneca Access 360, and many others — with program-specific protocols and active enrollment workflow.

Recent client results

A specialty pharmacy with strong oncology and rare disease focus enrolled approximately 320 patients annually in manufacturer PAPs within 12 months of go-live, recovering an estimated $4.8M in patient out-of-pocket exposure that would have driven therapy abandonment. A regional infusion provider serving immunology patients reduced first-fill abandonment from 23% to 7% by integrating PAP enrollment into the patient intake workflow rather than treating it as a separate reactive process. A specialty pharmacy serving Medicare hepatology patients identified 180 patients eligible for manufacturer assistance who had not been enrolled — closing that enrollment gap recovered $1.2M in annual therapy access.

320+

Annual PAP Enrollments (per specialty pharmacy)

Active

Enrollment Workflow
Standard

Quarterly

Manufacturer Program
Updates

How we support you

End-to-End manufacturer PAP operation

AnnexMed runs manufacturer PAP enrollment as a three-stage operation — eligibility evaluation and program-specific enrollment, recertification cycle management, and bridge and quick-start program coordination — so eligible patients get enrolled actively, continuing patients stay enrolled through recertification, and bridge programs prevent therapy delays during enrollment processing.

Eligibility & Enrollment

Program-specific workflow

  • Income documentation coordination
  • Insurance status verification
  • Diagnosis documentation collection
  • Prescriber attestation coordination
  • Program-specific eligibility evaluation
  • Enrollment submission per manufacturer protocol

Recertification

Continuing patient coverage

  • Annual recertification cycle tracking
  • Pre-expiry documentation refresh
  • Income recertification coordination
  • Continuing prescriber attestation
  • Coverage continuity protection
  • Recertification-to-dispensing workflow

Bridge & Quick-Start

Therapy delay prevention

  • Bridge program coordination during PA processing
  • Quick-start program enrollment for initial supply
  • Free drug program operational integration
  • Shipment and dispensing coordination
  • Program transition workflow (bridge → standard)
  • Manufacturer hub services coordination

Financial impact

What active PAP enrollment means in dollars?

For a specialty pharmacy with meaningful uninsured and underinsured patient populations, dedicated manufacturer PAP operations regularly deliver $1.5M–$5M+ in net annual financial benefit through patient out-of-pocket coverage, therapy abandonment reduction, continuing patient retention through recertification, and bridge program therapy delay prevention. Most specialty pharmacies achieve full ROI on PAP enrollment operations within 4–6 months.

Fast Results

PAP enrollment activity shows from the first month as active enrollment workflow replaces reactive intake. Therapy abandonment reduction follows within the first quarter as enrolled patients gain access to therapy they previously couldn’t afford.

Built for Manufacturer Program Reality

Quarterly program intelligence updates keep enrollment current as manufacturer eligibility criteria, program scope, and enrollment workflows evolve. Pharmacies don’t operate against stale program data.
Improvement Area
Estimated Annual Impact
Patient Out-of-Pocket Coverage via PAP

$2M – $5M annually in patient cost coverage

Therapy Abandonment Reduction (23% → 7%)

$500K – $1.5M annually in retained first-fill revenue

Continuing Patient PAP Recertification Capture

$300K – $1M annually in retained continuing therapy

Bridge Program Therapy Delay Prevention

$150K – $500K annually in prevented PA-window abandonment

Quick-Start Initial Supply Coordination

$100K – $400K annually in immediate therapy access

Free Drug Program Operational Integration

$80K – $300K annually in coordinated dispensing

Staffing Cost Reduction / Replacement

$150K – $400K annually

Manufacturer PAP performance targets

KPIs we hold ourselves accountable to — tracked in real time through your operational dashboards:
Performance Metric
Industry Benchmark
AnnexMed Target
Annual PAP Enrollment Rate

Industry avg: 60–120

300+ enrollments (mid-size specialty pharmacy)
Eligible Patient Capture Rate

Industry avg: 22–35%

85%+ of eligible population
Therapy Abandonment Rate (PAP-Eligible)

Industry avg: 22–32%

< 8%
Recertification On-Time Rate

Industry varies widely

98%+
Bridge Program Coordination

Industry: variable

Standard
Manufacturer Program Coverage

Most vendors cover 6–10 manufacturers

All major specialty manufacturers
Program Intelligence Update Cadence

Industry standard: Annual or ad-hoc

Quarterly
Documentation Completeness

Industry avg: 70–82%

98%+

Why Annexmed?

Reactive PAP vs. AnnexMed active enrollment

Manufacturer PAP enrollment is where specialty pharmacy access gets expanded or therapy abandonment accepted. Here’s how AnnexMed compares to typical in-house or generalist specialty pharmacy operations:
In-House / Traditional
AnnexMed Partnership
Enrollment Approach

Reactive when patients can't afford therapy

Active enrollment as standard patient intake step

Eligible Patient Capture

22–35% of eligible population

85%+ through active eligibility screening

Recertification Discipline

Inconsistent; continuing patients drop coverage

98%+ on-time recertification with pre-expiry workflow

Bridge Program Coordination

Variable; therapy delays during PA accepted

Standard bridge program enrollment during PA processing

Manufacturer Coverage

Top 6–10 manufacturers

All major specialty manufacturers across drug classes

Program Intelligence

Annual or ad-hoc updates

Quarterly program intelligence across all manufacturers

Quick-Start Enrollment

Rarely used

Standard for initial supply during enrollment processing

Cost to Operate

$70K–$100K per FTE for PAP specialist

30–40% lower with no hiring, attrition, or training overhead

Technology

Powered by proprietary AI & analytics

AnnexMed’s technology stack was built for payer-specific operational demands, not adapted from provider-side billing tools. Risk adjustment accuracy, payment integrity, and credentialing compliance each require different data models, workflow logic, and reporting architectures than provider RCM. Our platform reflects that.

AI Agents & Automation

AI Agents & Intelligent Automation deploys autonomous AI agents across the full revenue cycle, automating eligibility verification, prior authorization, claims processing, payment posting, and denial management at hospital scale and speed.

Data & Analytics Platform

Data & Analytics Platform delivers real-time Power BI dashboards built for hospital executive visibility, including system-wide KPIs, service line performance, payer analysis, productivity, financial forecasting, and national benchmarking insights.

Intelligent AR Management

Intelligent AR Management handles A/R follow-up at hospital scale with intelligent worklists prioritized by dollar value and aging, payer-specific follow-up rules, automated escalation for high-value accounts, and full accountability for every claim.

Computer Assisted Coding

Computer Assisted Coding orchestrates hospital coding operation, intelligent chart assignment by service line, TAT tracking with SLA monitoring, quality audits with accuracy scoring, and coder performance management at enterprise scale.

Together, these platforms create a fully instrumented RCM operation where nothing falls through the cracks. You don’t interact with these systems directly, but the results they enable show up directly in your financial performance.

user-bg

Ready to make manufacturer PAP a standard specialty pharmacy access lever?

Most specialty pharmacies identify $1.5M–$4M in patient out-of-pocket coverage and therapy abandonment prevention through active PAP enrollment in their first assessment. Schedule a no-obligation PAP Enrollment Audit.

Trusted by 100+ Healthcare Providers | AAPC, AHIMA & AAHAM Certified | SOC 2 Type II | HIPAA Compliant

Schedule a PAP enrollment audit
Request a therapy abandonment analysis
man-annex-CTA

Payer client outcomes

AnnexMed delivers measurable financial impact within the first 60 to 90 days of engagement. The following represent outcomes from active payer partnerships:

$15M–$40M

Risk
Adjustment

$18M–$50M

Payment
Integrity

6 Weeks

Credentialing Clearance

$15M–$50M+

Revenue
Impact

Case Studies

See the impact we deliver

Discover how AnnexMed reduces denials, accelerates reimbursements, and strengthens financial performance. Backed by measurable outcomes and proven RCM expertise, we deliver operational excellence, revenue stability, and sustainable growth you can trust.

Client Voices

See how our clients succeed

Hear from organizations that trust AnnexMed to reduce denials, accelerate reimbursements, and strengthen cash flow. Our expert support delivers measurable performance gains, operational efficiency, financial stability, and scalable growth.
Claims adjudication backlogs were delaying provider payments and increasing complaint volumes. AnnexMed took over processing, cleared the backlog in 30 days, and improved turnaround by 45%. Provider satisfaction scores climbed significantly, dispute volumes dropped, and our network relationships strengthened significantly.
Anx Image

Dr. Richard Calloway

Horizon Health Plan
Our payer operations team was overwhelmed with member inquiries, provider disputes, and claims rework. AnnexMed brought dedicated support that handled every function with accuracy and speed. Processing errors dropped by 60%, provider abrasion decreased, and our operational costs came down by nearly a third.
Anx Testimonial

Dr. Priya Menon

Crestview Insurance Partners
Managing claims accuracy, provider data, and member support internally was draining our resources. AnnexMed streamlined our payer operations end to end. Claims processing improved, provider onboarding accelerated, and our administrative burden reduced dramatically. They understand payer complexity like no other partner.
Anx Testimonial

Laura Simmons

Meridian Managed Care

Proven RCM expertise. Delivered at scale.

For over 20 years, AnnexMed has delivered RCM solutions nationwide, combining expert billing, coding, and AR support to drive measurable results and growth.

  • 20+ years of proven healthcare RCM experience
  • 1,500+ professionals supporting billing, coding & AR
  • 500+ certified coders across multiple specialties
  • 99%+ compliance with HIPAA and security standards
  • All 50 states served with consistent, scalable operations
Certification

Want to talk to our RCM experts?

    Annexmed-logo
    Powered by  GDPR Cookie Compliance
    Privacy Overview

    This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.